Author's reply - Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial

被引：1
|
作者：
Yamada, Hideto [1 ]
Deguchi, Masashi [2 ]
Saito, Shigeru [3 ]
Takeshita, Toshiyuki [4 ]
机构：
[1] Teine Keijinkai Hosp, Ctr Recurrent Pregnancy Loss, 1 40 Maeda 1 jho 12 chome Teine ku, Sapporo, Hokkaido 0068555, Japan
[2] Kobe Univ, Sch Med, Dept Obstet & Gynecol, 7 5 1 Kusunoki cho Chuo ku, Kobe, Hyogo, Japan
[3] Toyama Univ, Dept Obstet & Gynecol, 2630 Sugitani, Toyama, Japan
[4] Nippon Med Sch, Dept Obstet & Gynecol, 1 1 5 Sendagi,Bunkyo ku, Tokyo, Japan
来源：
ECLINICALMEDICINE | 2022年 / 52卷
关键词：
D O I：
10.1016/j.eclinm.2022.101617
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial
    Yamada, Hideto
    Deguchi, Masashi
    Saito, Shigeru
    Takeshita, Toshiyuki
    Mitsui, Mari
    Saito, Tsuyoshi
    Nagamatsu, Takeshi
    Takakuwa, Koichi
    Nakatsuka, Mikiya
    Yoneda, Satoshi
    Egashira, Katsuko
    Tachibana, Masahito
    Matsubara, Keiichi
    Honda, Ritsuo
    Fukui, Atsushi
    Tanaka, Kanji
    Sengoku, Kazuo
    Endo, Toshiaki
    Yata, Hiroaki
    ECLINICALMEDICINE, 2022, 50
  • [2] Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, placebo-controlled trial
    Christiansen, O. B.
    Larsen, E. C.
    Egerup, P.
    Lunoee, L.
    Egestad, L.
    Nielsen, H. S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 (04) : 500 - 508
  • [3] A randomised double-blind placebo-controlled trial of intravenous immunoglobulin in the treatment of secondary recurrent miscarriage
    Christiansen, O. B.
    Nielsen, H. S.
    Lunoe, L.
    Egestad, L.
    Larsen, E. C.
    HUMAN REPRODUCTION, 2014, 29 : 31 - 31
  • [4] Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial
    Norgaard-Pedersen, Caroline
    Nielsen, Kaspar
    Steffensen, Rudi
    Eriksen, Line
    Jorgensen, Malene Moller
    Kesmodel, Ulrik Schioler
    Christiansen, Ole Bjarne
    BMJ OPEN, 2022, 12 (09):
  • [5] Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses
    Yamamoto, Haruko
    Suzuki, Hiroshi
    ECLINICALMEDICINE, 2022, 52
  • [6] A randomised, double-blind, placebo-controlled trial: intravenous immunoglobulin treatment in patients with diffuse cutaneous systemic sclerosis
    Takehara, K.
    Ihn, H.
    Sato, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (02) : S151 - S156
  • [7] Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study
    Jablonowska, B
    Selbing, A
    Palfi, M
    Ernerudh, J
    Kjellberg, S
    Lindton, B
    HUMAN REPRODUCTION, 1999, 14 (03) : 838 - 841
  • [8] A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage
    Christiansen, OB
    Pedersen, B
    Rosgaard, A
    Husth, M
    HUMAN REPRODUCTION, 2002, 17 (03) : 809 - 816
  • [9] A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus - Reply
    Roberson, J
    Westerberg, B
    Stach, B
    AMERICAN JOURNAL OF OTOLOGY, 1997, 18 (02): : 268 - 269
  • [10] A placebo-controlled trial of intravenous immunoglobulin in the treatment of recurrent miscarriage
    Christiansen, O. B.
    Pedersen, B.
    Rosgaard, A.
    Husth, M.
    Varming, K.
    HUMAN REPRODUCTION, 2001, 16 : 95 - 95
12345